| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.4 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.4 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.043 | 0.4 |